ASX:ENPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
ENTROPY NEURODYNAMICS ORD
$0.035
$0.001 (2.78%)
Day Range
$0.035 - $0.035
52 Week Range
$0.025 - $0.046
Volume
2.01M
Avg Volume (10D)
4.68M
Market Cap
$55.34M
Price Chart
Market Statistics
Open$0.035
Previous Close$0.036
Day High$0.035
Day Low$0.035
52 Week High$0.046
52 Week Low$0.025
Valuation
Market Cap55.34M
Shares Outstanding1.58B
Price to Book7.49
Trading Activity
Volume2.01M
Value Traded70.18K
Bid$0.034 × 690,715
Ask$0.035 × 722,973
Performance
1 Day0.00%
5 Day7.25%
13 Week23.33%
52 Week19.35%
YTD12.12%
Technical Indicators
RSI (14)56.23
50-Day SMA$0.032
200-Day SMA$0.034
Latest News
Biotechnology
Entropy Neurodynamics Reports Breakthrough Results from Phase 2a TRP-8802 Study for Treating IBS
Entropy Neurodynamics announces Phase 2a TRP-8802 IBS results: 75% responders, clear gut-brain axis effect; de-risks program ahead of TRP-8803 trials.
2 min read
Biotechnology
Entropy Neurodynamics' TRP-8803 Trial Shows Repeatable Psychedelic Effects in BED Study
Entropy Neurodynamics reports repeatable psychedelic effects in TRP-8803 BED trial; Cohort 2 enrollment advancing; R&D incentives boost cash runway.
1 min read
Biotechnology
Entropy Neurodynamics Granted Australian Patent for TRP8803 to Treat Chronic Pain and Psychiatric Conditions
Entropy Neurodynamics (ASX: ENP) granted Australian patent for TRP8803 (IV psilocybin) for chronic pain and neuropsychiatric disorders; protection to 2042.
1 min read